TTY Biopharm Co Ltd

TTY Biopharm Company Limited develops and sells pharmaceutical and chemical drugs in Taiwan, the United States, and internationally. It operates through Oncology, Intensive Care, Healthcare, Export and CDMO, Other, and Re-investment business units. The company offers oncology drugs under brands such as Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Yondelis, Pemazyre, Pulmivex, Xpovio, Minjuvi, and Fustron. It also provides anti-infective drugs and anesthetics under Brosym, Bobimixyn, Colimycin, Cubicin, Lipo-AB, Flusine, Maxtam, Metacin, Flucelvax, Fluad, and Byfavo, as well as healthcare products for gastrointestinal health, bone health, and metabolic regulation under Algitab, Alginos, Bio-Cal Plus, and Sulfin. Additionally, it offers contract development and manufacturing (CDMO) services. The company was incorporated in 1960 and is headquartered in Taipei, Taiwan.